Last update Oct. 21, 2023

Meclofenamic Acid

Likely Compatibility

Fairly safe. Mild or unlikely adverse effects. Compatible under certain circumstances. Follow-up recommended. Read Commentary.

It is a low potency non-steroidal anti-inflammatory drug (NSAID) derived from anthranilic acid similar to mefenamic acid. It is used to treat mild to moderate pain in rheumatoid arthritis and osteoarthritis, dysmenorrhea and menorrhagia. It is administered orally in 3 to 4 daily doses.

On latest update no published data about breastfeeding were found

Its high plasma protein binding makes excretion into breast milk unlikely

Until more information on this drug concerning breastfeeding is available, a safer alternative is preferred.

Alternatives

  • Ibuprofen (Safe substance and/or breastfeeding is the best option.)
  • Mefenamic Acid (Safe substance and/or breastfeeding is the best option.)
  • Paracetamol (Safe substance and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Meclofenamic Acid is also known as


Meclofenamic Acid in other languages or writings:

Group

Meclofenamic Acid belongs to this group or family:

Tradenames

Main tradenames from several countries containing Meclofenamic Acid in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 100 %
Molecular weight 296 / 336 daltons
Protein Binding > 99 %
VD 0.13 - 0.62 l/Kg
pKa 3.79 -
Tmax 0.5 - 2 hours
T½ 0.8 - 5.3 (Metabol: 15) hours

References

  1. Mylan Ph. Meclofenamate sodium. Drug Summary. 2021 Full text (in our servers)
  2. Conroy MC, Randinitis EJ, Turner JL. Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium. Clin J Pain. 1991 Abstract

Total visits

9,133

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM